GlassScriptPhysician profile
Lisa Ann Burns-Serrano
NPI 1952397838
$8,045.86
in general payments reported to CMS, 2019-2025
50 companies · $1,129 in 2025
The $1,129 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $849 · 2020: $910 · 2021: $1,657 · 2022: $1,055 · 2023: $1,263 · 2024: $1,183 · 2025: $1,129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,575.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,599.11 | 2019-2025 | Ubrelvy, Qulipta, Creon |
| Astrazeneca Pharmaceuticals LP | $1,296.87 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Ibsa Pharma INC. | $501.17 | 2020-2025 | Tirosint, Tirosint, Licart |
| Exact Sciences Corporation | $411.27 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $376.70 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $335.24 | 2019-2023 | Belsomra, Steglujan, Segluromet |
| Bausch Health US, LLC | $307.32 | 2019-2023 | Wellbutrin, Aplenzin |
| Abbott Laboratories | $239.08 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Pfizer INC. | $232.57 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $206.45 | 2019-2022 | |
| Corcept Therapeutics | $158.98 | 2024-2025 | Korlym |
| Therapeuticsmd, INC. | $154.41 | 2019-2020 | |
| Aimmune Therapeutics, INC. | $144.87 | 2024-2025 | Zenpep |
| Biohaven Pharmaceuticals, INC. | $135.73 | 2020-2021 | |
| Allergan, INC. | $135.00 | 2020 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Burns-Serrano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.